Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Intraocular lens company eyeonics closes $16.2mm venture round

Executive Summary

Intraocular lens maker eyeonics brought in $16.2mm through a Series E financing led by new investor Versant Ventures, with participation from all returning investors: Brentwood Associates, Pequot Private Equity, ABS Ventures, and Entrepreneurs Fund. The company will use the money to expand sales of its crystalens device, an intraocular lens approved in 2003 that moves backwards and forwards with the eye's muscles to allow for a more continuous range of vision.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register